# A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)

> **NCT07237282** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Alberta** · enrollment: 27 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **BIOLOGICAL:** AVIHepC1
- **BIOLOGICAL:** Normal Saline

## Key facts

- **NCT ID:** NCT07237282
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07237282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07237282, "A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07237282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*